Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nasal transmucosal fentanyl citrate vs oral morphine sulphate for cancer breakthrough pain
2006-006678-12Phase 3Completed
- Sponsor
- Haupt Pharma Wolfratshausen
- Start
- Apr 2007
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of fentanyl in breakthrough pain and cancer pain (2 arms), sponsored by Haupt Pharma Wolfratshausen. Primary endpoints: Pain intensity difference at 15 minutes and Pain intensity difference at 30 minutes. Started Apr 2007; status: completed.
02
Drugs
fentanyl
03
Conditions
breakthrough paincancer pain
Beyond the preview
Go deeper on 2006-006678-12.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-006678-12.